Member Info for x54v

"Meanwhile, Poolbeg Pharma and OneThree Biotech have discovered novel drug targets for the treatment of respiratory syncytial virus (RSV) using an AI programme. ....When these sorts of results are happening now, it is exciting to imagine what the future holds."

https://www.ddw-online.com/slas2023-we-have-the-building-blocks-onto-the-building-22039-202302/

https://www.thisismoney.co.uk/money/investing/article-11745243/SMALL-CAP-IDEAS-small-drug-firms-set-benefit-RSV-vaccines.html

https://www.thisismoney.co.uk/money/investing/article-11745243/SMALL-CAP-IDEAS-small-drug-firms-set-benefit-RSV-vaccines.html

100k and 200k buys at 10p printed after the bell.

422,887 bought earlier in the day at 9.8p as well.

Accumulation continues by the looks of it.

Interesting buying this week with people so keen to get hold of stock they are happy to pay a significant premium. Fairly chunky blocks as well.

Jan 30th
-----------
650,000 @ 10p (9 - 9.3) - £65k
1,257,308 @ 10 (9 - 9.3) - £125.7k

Feb 3rd
----------
547,870 @ 9.9 (9.1 - 9.5) - £54.2k

Somebody very keen if they are willing to pay way over the offer.

Chunky buy as well.

https://www.investorschronicle.co.uk/ideas/2023/01/31/bargain-shares-and-a-high-yield-with-this-developer/

A further large buy of 1,257,308 @ 10p appearing as a late print.

£126k bought well above the quoted offer at the time.

650k buy @ 10p with quoted offer at 9.3.

Somebody very keen.

"Angola

M&P’s working interest production (20%) from Block 3/05 in 2022 is 3,732 bopd (gross production: 18,660 bopd), up 9% from 2021.

Discussions regarding the extension of the Block 3/05 licence beyond its current term of June 2025 are now well underway. It is expected that the licence extension will be accompanied by new fiscal terms to strengthen the economics of the permit."

https://www.maureletprom.fr/en/documents/download/1414/activity-for-the-year-2022

From 22:06

https://audioboom.com/posts/8229819-saturday-brunch-malcy-s-bucket-list-2023-pxen-txp-zphr-sle-char-sqz-wen-sou-iog-eog

https://www.malcysblog.com/2023/01/the-2023-bucket-list/

"Afentra which I wrote up yesterday is now almost ready to complete the Angola deal after Ministerial approval and will close within weeks.This will prove to be a fantastic acquisition and I’m sure that there will be more to come as Paul McDade and his excellent team bed in."

Vox - hVIVO’s army of admirers swells

http://tinyurl.com/2cjyxbum

https://www.**********.co.uk/articles/hvivo-s-army-of-admirers-swells-8f815c0/

“As the co-founder of Amryt Pharma, I am delighted with today’s news on its sale for $1.48bn.

We aim to repeat the same exercise with Poolbeg Pharma…”

https://twitter.com/poolbegpharma/status/1612386837326094337?s=61&t=n5w5BVRDZWXmlW0t-spkWg

https://twitter.com/BobInvest/status/1596081842448662528

"Sonangol has divested partial stakes in some of its Angolan portfolio for $766 million with deals including the sale of a 20% non-operated interest in Block 3/05 for $80 million and contingent payments of up to $50 million, and a 40% interest in Block 23 for $500,000 to independent oil and gas company Afentra."

"However, these deals represent just the start of Angola’s M&A activity with a host of new agreements expected to be signed in the following months owing to both Sonangol’s divestment strategy and Angola’s high potential upstream market."

https://energycapitalpower.com/angola-upstream-success-growth-investment

https://energycapitalandpower.africa-newsroom.com/press/afentra-chief-executive-officer-ceo-paul-mcdade-to-discuss-angolan-exploration-at-angola-oil-and-gas-aog-2022?lang=en

https://energycapitalpower.com/afentra-coo-ian-cloke-aog-2022

Indeed, but not the ‘Operators and Investors’ panel part as underlined in tweet.